A pan-cancer spatial atlas from Asia Pacific reveals recurrent spatial theratopes

Abstract Here we generated a pan-cancer spatial atlas of 400 tumours across 13 tissue types and 26 subtypes from the Asia-Pacific, a region under-represented in existing pan-cancer datasets. In a multimodal cohort we integrated single-cell spatial transcriptomics (1,999 genes) with more than 70 proteins measured in the same cells as built-in validation, alongside clinical data including ancestry, age, sex and survival. ASTRA1.0 revealed that each cancer subtype has distinct expression profiles and cellular compositions. Despite this heterogeneity, we identified eight recurrent spatial cellular neighbourhoods shared across tissue types, with macrophages as key organisers. We further developed a framework to quantify the co-localisation of FDA-approved drug targets with surrounding cell types. This framework classified tumours into four Spatial Theratope subtypes, each defined by a distinct signature of co-localised targets. The VEGF-A–PD-L1 pair, targeted by bevacizumab and atezolizumab, recurred across tumour types and neighbourhoods. Spatial Theratope subtypes and neighbourhood composition were each associated with progression-free survival (PFS) in the discovery cohort, and their combination was also associated with PFS in an independent cohort of 25 patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab. The ASTRA atlas provides a community resource for nominating rational, spatially informed combination therapies across cancers.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-13
DOI
https://doi.org/10.21203/rs.3.rs-11641830/v1
Primary Topic
Single-cell and spatial transcriptomics
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

A pan-cancer spatial atlas from Asia Pacific reveals recurrent spatial theratopes

Junki Koike, Helen Marie McGuire, Kentaro Inamura, Noriyoshi Fukushima et al.
6 links
Research Square
Single-cell and spatial transcriptomics
preprint

A pan-cancer spatial atlas from Asia Pacific reveals recurrent spatial theratopes

Junki Koike, Helen Marie McGuire, Kentaro Inamura, Noriyoshi Fukushima, 仁木 利朗, Jacob George, Ruby Yun‐Ju Huang, Masaki Shiota, Toyoyuki Hanazawa, Daisuke Matsubara, Hitomi Kawai, Shota Sasagawa, Takuya Nakagawa, Egor Revkov, Sotaro Chikamatsu, Ryutaro Sekimoto, Skye van Esch, Yi-Chia Chiu, Rie Horii, Atsushi Ono, Ankur Sharma, Yutaka Suzuki, Satoi Nagasawa, Inês Pires da Silva, Takayuki Ueno, Atsushi Kaneda, Hidewaki Nakagawa, Yutaka Hatanaka, Elgene Lim, Ayako Suzuki, Annabel Faulkner, Dana Idais, Masaya Onishi, Makoto Yamagishi, Shiro Oka, Yukinori Ozaki, Lucy Chhuo, Wei-Chou Lin, Georgina Long, Kei Asayama, Abhishek Singh, Jordan Conway, Masakazu Fujii, Ryota Matsuoka, Thang Le, Liang Qiao, Merrin Eapen, Yoshiki Otsuka, Masahito Shimizu, Lin-Hung Huang
preprint en

Abstract

Abstract Here we generated a pan-cancer spatial atlas of 400 tumours across 13 tissue types and 26 subtypes from the Asia-Pacific, a region under-represented in existing pan-cancer datasets. In a multimodal cohort we integrated single-cell spatial transcriptomics (1,999 genes) with more than 70 proteins measured in the same cells as built-in validation, alongside clinical data including ancestry, age, sex and survival. ASTRA1.0 revealed that each cancer subtype has distinct expression profiles and cellular compositions. Despite this heterogeneity, we identified eight recurrent spatial cellular neighbourhoods shared across tissue types, with macrophages as key organisers. We further developed a framework to quantify the co-localisation of FDA-approved drug targets with surrounding cell types. This framework classified tumours into four Spatial Theratope subtypes, each defined by a distinct signature of co-localised targets. The VEGF-A–PD-L1 pair, targeted by bevacizumab and atezolizumab, recurred across tumour types and neighbourhoods. Spatial Theratope subtypes and neighbourhood composition were each associated with progression-free survival (PFS) in the discovery cohort, and their combination was also associated with PFS in an independent cohort of 25 patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab. The ASTRA atlas provides a community resource for nominating rational, spatially informed combination therapies across cancers.

Research Square
Hiroshima University (JP), The University of Sydney (AU), Kyushu University (JP), Garvan Institute of Medical Research (AU), University of Tsukuba (JP), Jichi Medical University (JP), Chiba University (JP), National Taiwan University (TW), Hokkaido University (JP), Royal North Shore Hospital (AU), Westmead Hospital (AU), UNSW Sydney (AU), Melanoma Institute Australia (AU), Hokkaido University Hospital (JP), RIKEN Center for Integrative Medical Sciences (JP), The Kinghorn Cancer Centre (AU), Gifu University (JP), Japanese Foundation For Cancer Research (JP), The University of Tokyo (JP)
Japan Agency for Medical Research and Development, National Computational Infrastructure, University of Tokyo, National Health and Medical Research Council, Japan Society for the Promotion of Science, Medical Research Future Fund
Good health and well-being
Single-cell and spatial transcriptomics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon